Hypnap LLC
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A47C (CHAIRS; SOFAS; Beds).
The verdict
According to USPTO PatentsView, Hypnap ranks #40,813 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.
- #40,813
- of 49,997 US assignees by volume
- Top 43%
- by Innovation Score (37.6/100)
- 16.0
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R40813 · US Corporation #40,813 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #40,813/49,997
- PHOTO-FINISH Hänel &
- CPC-NARROW A47C · 5 areas
- INNOV-THIN 37.6/100
- CLAIMS-RICH 16.0 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2020–2024 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Hänel & Co. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Hypnap’s 37.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Hypnap
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Hypnap · this assignee
Hypnap · this assignee
38 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Hypnap's Innovation Score is 37.6/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Hypnap?
Each dot is one of Hypnap’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hypnap’s own 16.0 claims/patent is at or below the 16.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Hypnap's grants concentrate
Hypnap LLC is a focused PatentsView assignee: 5 CPC subclasses with 83.3% of grants classified under A47C (CHAIRS; SOFAS; Beds). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2022. By volume, Hypnap sits between HyperBranch Medical Technology, Inc. and I2 Pharmaceuticals, Inc..
Hypnap's three-year grant acceleration
Hypnap LLC shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Hypnap's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Hyperbranch Medic…
HyperBranch Medical Technology, Inc.
6 patents
- Hyperframe
Hyperframe, Inc.
6 patents
- Hyperspectral
Hyperspectral Corp.
6 patents
- Hyphen
Hyphen Technologies, Inc.
6 patents
- Hysolate
Hysolate Ltd.
6 patents
- Hänel &
Hänel & Co.
6 patents
- I&Eyeenterprises
I&EyeEnterprises, LLC
6 patents
- I2 Pharmaceuticals
I2 Pharmaceuticals, Inc.
6 patents
- Hypnap ◀
Hypnap LLC
6 patents
What this shows Hypnap holds 6 patents at rank #40,802, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Hypnap
By rank, the assignees closest to #40,802 in granted patent volume.
- HyperBranch Medical Technology, Inc. #40,798 · 6 patents
- Hyperframe, Inc. #40,799 · 6 patents
- Hyperspectral Corp. #40,800 · 6 patents
- Hyphen Technologies, Inc. #40,801 · 6 patents
- Hysolate Ltd. #40,803 · 6 patents
- Hänel & Co. #40,804 · 6 patents
- I&EyeEnterprises, LLC #40,805 · 6 patents
- I2 Pharmaceuticals, Inc. #40,806 · 6 patents
Leaders in A47C (Chairs)
Other assignees with the most granted patents in Hypnap's primary technology class.
Hypnap's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 43% higher than 57% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 33.3% |
| 2022 | 1 | 16.7% |
| 2023 | 2 | 33.3% |
| 2024 | 1 | 16.7% |
Which technologies does Hypnap LLC patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Hypnap LLC's patent record in context - here's where to go next.
- Hypnap LLC's lead technology class is A47C (CHAIRS; SOFAS; Beds), 83.3% of its portfolio - see every assignee active in that class. Explore A47C
- Ranked #40,813 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Hypnap LLC against HyperBranch Medical Technology, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 37.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.